| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |